| 000 | 01526 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518023811.0 | ||
| 264 | 0 | _c20191209 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1098-2825 | ||
| 024 | 7 |
_a10.1002/jcla.22862 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhou, Li | |
| 245 | 0 | 0 |
_aThe clinical value of hematological markers in rheumatoid arthritis patients treated with tocilizumab. _h[electronic resource] |
| 260 |
_bJournal of clinical laboratory analysis _cJun 2019 |
||
| 300 |
_ae22862 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemoglobins _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 | _aPlatelet Count |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aXiao, Dong-Mei | |
| 700 | 1 | _aQin, Wen | |
| 700 | 1 | _aXie, Bin-Hua | |
| 700 | 1 | _aWang, Ting-Hui | |
| 700 | 1 | _aHuang, Hua | |
| 700 | 1 | _aZhao, Bao-Jing | |
| 700 | 1 | _aHan, Xi | |
| 700 | 1 | _aSun, Qing-Qing | |
| 700 | 1 | _aWu, Xiu-Di | |
| 700 | 1 | _aCen, Han | |
| 773 | 0 |
_tJournal of clinical laboratory analysis _gvol. 33 _gno. 5 _gp. e22862 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jcla.22862 _zAvailable from publisher's website |
| 999 |
_c29387655 _d29387655 |
||